4 Largecap Kotak Mutual Fund Stocks to Watch for Future Multibagger Potential: Shriram Finance, Torrent Pharma, BSE and Indian Bank
- October 29, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Shriram Finance Rs 826.05. Torrent Pharma Rs 4,557. BSE Rs 3,485. Indian Bank Rs 839.80. Market caps from Rs 1.11 lakh crore to Rs 2.05 lakh crore. Data as of 28 Oct 2026.
Quick Answer
Shriram Finance, Torrent Pharma, BSE and Indian Bank are the 4 picks in this Kotak mutual fund stocks watchlist, with market caps between Rs 1.11 lakh crore and Rs 2.05 lakh crore. Shriram Finance stands out for the largest market cap at Rs 2,04,755 crore, while Torrent Pharma offers 20.34% revenue growth in FY26. PE ratios run from 8.36 to 80.23, so compare each one with its industry PE before investing. All figures are as of 28 October 2026.
Kotak mutual fund stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Shriram Finance, Torrent Pharma, BSE and Indian Bank meet that test, with market caps from Rs 1.11 lakh crore to Rs 2.05 lakh crore and Shriram Finance offering the largest market cap at Rs 2,04,755 crore. Each of these companies has Kotak Mutual Fund or one of its schemes listed among its top domestic institutional holders, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with Kotak Mutual Fund or one of its schemes listed among its top domestic institutional holders, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening Kotak mutual fund stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Kotak Mutual Fund Stocks and Why Do They Attract Multibagger Interest?
Kotak mutual fund stocks are shares of large companies in which Kotak Mutual Fund or one of its schemes is named among the top domestic institutional holders in the latest shareholding pattern. The four here cover lending, pharmaceuticals, a stock exchange and public sector banking.
When a leading fund house like Kotak Mutual Fund holds a large stake, it shows that its research teams have studied the business closely and backed it with investors money. For Kotak mutual fund stocks, both FY26 and the latest quarter showed growth. For Kotak mutual fund stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of Kotak mutual fund stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for Kotak mutual fund stocks before you decide.
Kotak Mutual Fund Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book
Prices are closing prices as of 28 October 2026. Indian Bank has the lowest PE of the group at 8.36, while BSE posts the highest return on equity at 37.42%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Shriram Finance | 826.05 | 2,04,755 | 18.09 | 17.68 | 15.21% | 1.94 | 662.25 to 1,153.70 |
| Torrent Pharmaceuticals | 4,557 | 1,72,983 | 80.23 | 36.42 | 25.49% | 20.57 | 3,480.60 to 5,250.00 |
| BSE Ltd | 3,485 | 1,49,244 | 52.89 | 42.42 | 37.42% | 22.36 | 2,326.10 to 4,446.80 |
| Indian Bank | 839.80 | 1,10,586 | 8.36 | 12.02 | 16.02% | 1.38 | 756.50 to 1,000.90 |
Shriram Finance: 38.64% Profit CAGR Since FY22
Shriram Finance is a major NBFC focused on commercial vehicle, small business and personal loans. It reported FY26 total income of Rs 48,192.65 crore, up 15.13% year on year, and net profit of Rs 10,004.20 crore, up 6.16%. Net profit has compounded at 38.64% a year since FY22, while total income has grown 25.75% a year.
In the June 2026 quarter, total income rose 16.26% to Rs 13,418.74 crore and net profit grew 59.95% to Rs 3,447.26 crore. The share price has gained 239.61% over five years and 40.91% over the past year. Domestic institutions raised their holding from 18.66% in September 2025 to 19.90% in June 2026. The stock trades at a PE of 18.09 against an industry PE of 17.68, with a return on equity of 15.21%.
Torrent Pharma: 28.79% Profit CAGR Since FY22
Torrent Pharmaceuticals makes branded medicines for chronic therapies such as cardiac, gastro-intestinal and central nervous system care in India and overseas. It reported FY26 revenue of Rs 13,886.15 crore, up 20.34% year on year, and net profit of Rs 2,138.18 crore, up 11.87%. Net profit has compounded at 28.79% a year since FY22, while revenue has grown 12.38% a year. Operating margin was 22.70% in FY26.
The stock trades at a PE of 80.23 against an industry PE of 36.42, with a return on equity of 25.49%. In the June 2026 quarter, revenue rose 56.29% to Rs 4,909 crore and net profit grew 3.28% to Rs 566 crore. The share price has gained 194.63% over five years and 29.72% over the past year. Domestic institutions raised their holding from 9.28% in September 2025 to 12.87% in July 2026.
BSE: 78.30% Profit CAGR Since FY22
BSE Ltd operates one of India’s two major stock exchanges and earns from trading, listing, data and clearing services. It reported FY26 revenue of Rs 5,148.10 crore, up 59.07% year on year, and net profit of Rs 2,475.30 crore, up 87.94%. Net profit has compounded at 78.30% a year since FY22, while revenue has grown 56.26% a year. Operating margin was 68.39% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.
In the June 2026 quarter, revenue rose 63.41% to Rs 1,706.72 crore and net profit grew 62.15% to Rs 872.66 crore. The share price has gained 2101.66% over five years and 37.49% over the past year. Domestic institutions raised their holding from 13.51% in June 2025 to 24.15% in June 2026. The stock trades at a PE of 52.89 against an industry PE of 42.42, with a return on equity of 37.42%.
Indian Bank: 32.28% Profit CAGR Since FY22
Indian Bank is a government-owned bank with a strong presence in South India and a growing national network. It reported FY26 total income of Rs 78,332.70 crore, up 8.72% year on year, and net profit of Rs 12,226.99 crore, up 11.21%. Net profit has compounded at 32.28% a year since FY22, while total income has grown 14.07% a year.
The stock trades at a PE of 8.36 against an industry PE of 12.02, below the sector average, with a return on equity of 16.02%. The dividend yield is 2.22%. In the September 2026 quarter, total income rose 21.09% to Rs 23,335.98 crore and net profit grew 13.36% to Rs 3,446.86 crore. The share price has gained 396.82% over five years and 10.47% over the past year. Foreign investors raised their holding from 4.68% in September 2025 to 6.86% in September 2026.
Kotak Mutual Fund Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these Kotak mutual fund stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Total Income (Rs Cr) | Net Profit (Rs Cr) | Income Growth (YoY) | 4-Year Income CAGR | 4-Year Net Profit CAGR |
|---|---|---|---|---|---|
| Shriram Finance | 48,192.65 | 10,004.20 | 15.13% | 25.75% | 38.64% |
| Torrent Pharma | 13,886.15 | 2,138.18 | 20.34% | 12.38% | 28.79% |
| BSE | 5,148.10 | 2,475.30 | 59.07% | 56.26% | 78.30% |
| Indian Bank | 78,332.70 | 12,226.99 | 8.72% | 14.07% | 32.28% |
Check the Univest Screener for live data on these Kotak mutual fund stocks
Institutional Holding in Shriram Finance, Torrent Pharma, BSE and Indian Bank
Institutional holding shows who is backing these Kotak mutual fund stocks alongside the promoter. The table uses the latest reported quarter for each. Shriram Finance has the deepest institutional backing, with FII and DII together holding 74.67% as of June 2026. Domestic institutions increased their holding over the past year in Shriram Finance (from 18.66% to 19.90%), Torrent Pharma (from 9.28% to 12.87%) and BSE (from 13.51% to 24.15%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Shriram Finance | 20.30% | 54.77% | 19.90% | 5.04% | June 2026 |
| Torrent Pharma | 60.78% | 17.97% | 12.87% | 8.38% | July 2026 |
| BSE | Nil | 21.32% | 24.15% | 54.53% | June 2026 |
| Indian Bank | 73.84% | 6.86% | 16.77% | 2.53% | September 2026 |
Risks to Weigh in Kotak Mutual Fund Stocks
Being careful with Kotak mutual fund stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Torrent Pharma trades at a PE of 80.23 against an industry PE of 36.42, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Kotak Mutual Fund Stocks
Picking from Kotak mutual fund stocks comes down to four checks, applied in order.
- Check asset quality and net interest margin first, then return on equity and price to book. Debt-to-equity does not apply to lenders.
- Compare each PE with the industry PE (12.02 to 42.42) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Shriram Finance, Torrent Pharma, BSE and Indian Bank live prices.
Conclusion
Among Kotak mutual fund stocks, Shriram Finance stands out for the largest market cap at Rs 2,04,755 crore, Torrent Pharma for 20.34% revenue growth in FY26, BSE for the highest return on equity at 37.42% and Indian Bank for the lowest PE of the group at 8.36. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing Kotak mutual fund stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Kotak Mutual Fund Stocks to Watch
Which are the best Kotak mutual fund stocks to watch for multibagger potential?
Ans. Shriram Finance, Torrent Pharma, BSE and Indian Bank are the 4 names this list highlights, with market caps of Rs 2,04,755 crore, Rs 1,72,983 crore, Rs 1,49,244 crore and Rs 1,10,586 crore respectively. Shriram Finance is notable for the largest market cap at Rs 2,04,755 crore. Torrent Pharma stands out for 20.34% revenue growth in FY26. BSE offers the highest return on equity at 37.42%. Indian Bank brings the lowest PE of the group at 8.36. These are watchlist names for Kotak mutual fund stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is BSE a good stock for long-term investors?
Ans. BSE has a return on equity of 37.42%, a PE of 52.89 against an industry PE of 42.42 and a market cap of Rs 1,49,244 crore. Net profit has compounded at 78.30% a year since FY22, and FY26 revenue rose 59.07% while June 2026 quarter net profit grew 62.15%. Long-term returns in Kotak mutual fund stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Shriram Finance become a multibagger from here?
Ans. Shriram Finance has already gained 239.61% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in Kotak mutual fund stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.64% a year since FY22, and FY26 revenue rose 15.13%. At a PE of 18.09 against an industry PE of 17.68, valuation should be checked against that growth before investing.
What is the market cap of Shriram Finance, Torrent Pharma, BSE and Indian Bank?
Ans. As of 28 October 2026, Shriram Finance has a market cap of Rs 2,04,755 crore, Torrent Pharma has a market cap of Rs 1,72,983 crore, BSE has a market cap of Rs 1,49,244 crore and Indian Bank has a market cap of Rs 1,10,586 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on Kotak mutual fund stocks.
What are the risks of investing in Kotak mutual fund stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Torrent Pharma trades at a PE of 80.23 against an industry PE of 36.42, so earnings growth needs to hold up.
Why is Torrent Pharma trading at a PE of 80.23?
Ans. Torrent Pharma’s PE of 80.23 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 25.49%, profit growth of 28.79% a year since FY22 and FY26 revenue growth of 20.34%, which also means the stock is more sensitive if growth slows. Investors in Kotak mutual fund stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Shriram Finance, Torrent Pharma, BSE and Indian Bank?
Ans. As of the latest reported quarter, FII and DII together hold 74.67% of Shriram Finance (54.77% and 19.90%), 30.84% of Torrent Pharma (17.97% and 12.87%), 45.47% of BSE (21.32% and 24.15%) and 23.63% of Indian Bank (6.86% and 16.77%). Rising institutional holding is a useful signal in Kotak mutual fund stocks, though it should be read with earnings trends rather than on its own.
